Related Experiment Video
Updated: Jul 21, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Pilot study: prognostic significance of semi-quantitative parameters in baseline fluorine‑18 fluorodeoxyglucose
Nahla Dessoki Elsayed1, Mirna Tarek Mohamed1, Mahasen Amin Abou Gabal1
1Department of Nuclear Medicine.
Background:
Breast cancer demonstrates heterogeneous clinical behavior, underscoring the need for reliable prognostic biomarkers. Semi-quantitative parameters derived from fluorine‑18 fluorodeoxyglucose PET/CT, including spleen maximum standardized uptake value (SUVmax) and spleen-to-liver SUVmax ratio (SLR), may reflect systemic inflammatory activity and predict outcomes.
Objective:
To assess the prognostic significance of baseline spleen SUVmax and SLR, compared with other PET/computed tomography (CT)-derived parameters, in predicting disease-free survival (DFS) in nonmetastatic breast cancer.
Methods:
Ninety-two female patients with pathologically confirmed invasive breast cancer underwent baseline fluorine‑18 fluorodeoxyglucose PET/CT before treatment. SUVmax values for primary tumor, spleen, and bone marrow were measured, and SLR and bone marrow-to-liver SUVmax ratios were calculated. Associations with clinicopathological features were analyzed using chi-square and ANOVA tests. DFS predictors were evaluated using Cox regression and Kaplan-Meier analysis.
Results:
Higher spleen SUVmax and SLR were significantly associated with larger tumor size, advanced stage, higher grade, hormone receptor negativity, and triple-negative subtype ( P < 0.05). Patients with progressive disease had higher spleen SUVmax (2.93 ± 0.50) and SLR (0.87 ± 0.06) than those with complete remission ( P < 0.001). In univariate Cox regression, SLR remained a strong predictor of DFS [hazard ratio = 6.12, 95% confidence interval (CI): 2.05-18.25, P = 0.001]. In multivariate analysis including SLR, Ki-67, stage, nodal status, and molecular subtype, only SLR remained independently significant (hazard ratio = 6.12, 95% CI: 2.05-18.25, P = 0.001). Patients with SLR greater than 0.7083 had significantly shorter mean survival (14.5 vs. 31.6 months, P < 0.001).
Conclusion:
Baseline SLR is a strong prognostic marker in nonmetastatic breast cancer along with tumor SUVmax and spleen SUVmax, and may aid in risk stratification and treatment planning.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
09:58Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Related Concept Videos
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...